Mitral Valve Area Using 3-dimensional Transesophageal Echocardiography
MVA
Determination of Mitral Valve Area After Mitral Valve Repair Surgery for Mitral Stenosis Using 3-dimensional Transesophageal Echocardiography
1 other identifier
observational
86
1 country
1
Brief Summary
Even during mitral valve repair procedure (MVP) for severe mitral stenosis (MS), the intraoperative assessment of mitral valve area (MVA) is necessary for evaluating the severity of MS before the repair and excluding residual MS for immediate determination of the success of the repair procedure and postoperative prognosis. For this purpose, several methods have been applied by introperative transesophageal echocardiography (TEE): pressure half-time (PHT) of mitral inflow Doppler and 2-dimensional (2D) planimetry methods have been widely used in clinical practice. However, especially after MVP, the PHT method is usually unreliable because it usually underestimates the MVA due to various intraoperative hemodynamic factors. The authors hypothesized that the MVA determined by 3D TEE would be more accurate than that by PHT during immediate post-MVP procedure in severe MS patients and comparable to postoperative MVA determined by MDCT. Therefore, the present study determined the MVA by using PHT, 3D planimetry and MDCT before and after the MVP procedure in severe MS patients and analyzed them to evaluate 3D TEE's utility for evaluation of MVA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 23, 2012
CompletedFirst Posted
Study publicly available on registry
September 27, 2012
CompletedSeptember 27, 2012
September 1, 2012
3 months
September 23, 2012
September 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
mitral valve area determined by 3D planimetry
within 1 hour after the weaning from CPB
mitral valve area determined by pressure-half time
within 1 hour after the weaning from CPB
mital valve area determined by multi-detactor CT scan
within 7 days weaning from CPB
Eligibility Criteria
mitral valve repair mitral stenosis
You may qualify if:
- patients scheduled to undergo elective mitral valve repair surgery
- more than moderate mitral stenosis
- left atrial enlargement
- signed written informed consent agreements
You may not qualify if:
- urgent or emergency case
- other concurrent valvular surgery
- patient age \< 18 years,
- reduced left or right ventricular function (ejection fraction \< 40%),
- mitral regurgitation grade more than moderate
- repeated surgery for cardiac valvular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Konkuk University Medical Center
Seoul, Seoul, 143-729, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Tae-Yop Kim, MD PhD
Konkuk University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor of Anesthesiology
Study Record Dates
First Submitted
September 23, 2012
First Posted
September 27, 2012
Study Start
December 1, 2011
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
September 27, 2012
Record last verified: 2012-09